Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat domain 9B (TTC9B) is a TPR-containing protein that acts as a scaffold for protein-protein interactions. Its epigenetic regulation is sensitive to estrogen, and changes in TTC9B DNA methylation have been linked to the hormonal modulation of the brain, especially during pregnancy. Human studies highlight TTC9B methylation status as predictive of postpartum depression, indicating a potential role as a psychiatric biomarker. TTC9B is not currently established as a therapeutic target or drug receptor, but its functional domains suggest regulatory and scaffolding capacity typical for TPR proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 9B (TTC9B).